Why Monoclonal Antibodies Remain the Fastest-Growing Drug Class

Ajouter une nouvelle offre d'emploi Autre

2025-12-12 07:33:31 - Traduire

Monoclonal antibodies (mAbs) have transformed modern medicine by offering precise, targeted treatment for a wide range of diseases including cancer, autoimmune conditions, infectious diseases, and chronic inflammatory disorders. As biotechnology advances and demand for personalized therapies rises, monoclonal antibodies have become one of the fastest-growing classes of biopharmaceuticals...

0 Commentaires 0 Parts 417 Vue 0 Aperçu